Cardiovascular and Metabolic Market Research and Competitive Intelligence Leaders
by
![]() |
![]() |
![]() |
![]() |
![]() |
CVrg Full Support™
CVrg Market Strategies™
CVrg Conference™
CVrg Sentinel™
CVrg Insights™
CVrg Advisory™
Cardiovascular
Acute Coronary Syndromes
Atrial Fibrillation & Stroke Prevention in AFib
Dyslipidemia/Atherosclerosis
Heart Failure
Peripheral Arterial Disease
Pulmonary Hypertension
Venous Thrombosis
Metabolic
Chronic Kidney Disease
Non-Alcoholic Steatohepatitis
Obesity
Type 1 Diabetes
Type 2 Diabetes
CVrg Full Support™
CVrg Market Strategies™
CVrg Conference™
CVrg Sentinel™
CVrg Insights™
CVrg Advisory™
About CVrg
Our Team
Careers
Contact
Home
CardioVascular
Acute Coronary Syndromes
Atrial Fibrillation & Stroke Prevention in AFib
Dyslipidemia/Atherosclerosis
Heart Failure
Peripheral Arterial Disease
Pulmonary Hypertension
Venous Thrombosis
Metabolic
Chronic Kidney Disease
Non-Alcoholic Steatohepatitis
Obesity
Type 1 Diabetes
Type 2 Diabetes
Conferences
ACC
ERA
EASL
ADA
HF-ESC
ESC
EASD
ASN
AASLD
AHA
ASH
Chung I Choi has been with CVrg since 2007 and brings 20 years of biotechnology and pharmaceutical consulting experience to her clients. Her analytical capabilities span a wide range of areas supporting the product development and competitive intelligence functions within companies, such as opportunity assessments, target profile product development, pipeline prioritization, conference coverage, and market forecasting. She excels at conducting primary research with KOLs and is an expert at integrating analyses from primary and secondary research to determine the future marketplace. She received her B.A. from the University of California, Berkeley in Biochemistry and Political Economics.